#202 - Peter on nutrition, disease prevention, sleep, and more — looking back on the last 100 episodes

Episode Summary

Executive Summary: Peter Atiyah reflects on how his views evolved across the last 100 episodes, emphasizing “strong convictions, loosely held.” Major shifts include more aggressive cancer screening and immunotherapy optimism, earlier/lower ApoB lowering for ASCVD prevention, skepticism about NAD and psychedelic hype, stronger emphasis on protein and resistance training, and a more nuanced approach to sleep aids. The episode ends with a detailed Formula One primer and season outlook.

Main Topics: Strong convictions, loosely held (Priority: 5/5): Atiayah explains why updating beliefs with new evidence is essential in science and medicine, contrasting it with the rigidity often seen in politics and in print publishing. Cancer screening and immunotherapy (Priority: 5/5): He becomes more aggressive about GI cancer screening, especially colonoscopy, and more optimistic that designer immunotherapies and TIL/adoptive cell therapies could eradicate many metastatic solid tumors within a decade. ASCVD prevention and ApoB lowering (Priority: 5/5): He argues for earlier and more aggressive ApoB reduction, potentially into the 20-30 mg/dL range starting in the 20s, to nearly eliminate atherosclerotic disease risk. Nutrition, fasting, and protein (Priority: 4/5): He concludes that time-restricted feeding likely works mainly through calorie reduction, warns about lean-mass loss in some fasters, and argues most people need far more protein than the RDA. Exercise, strength, and recovery (Priority: 5/5): He elevates exercise as perhaps the most powerful longevity intervention, highlighting VO2 max, strength, grip strength, and the practical realities of training through shoulder surgery recovery. Molecules, sleep, and psychedelics (Priority: 4/5): He is less enthusiastic about NAD precursors and cautious about psychedelic “cure-all” narratives, while favoring trazodone over phenibut or Ambien for sleep maintenance. Formula One strategy and season outlook (Priority: 3/5): He gives a detailed explanation of F1 tires, engines, chassis, qualifying, and race strategy, then previews a more competitive season with Ferrari, Red Bull, and Mercedes all in contention.

Key Arguments: Changing one’s mind is a strength in science and medicine because new evidence should update prior assumptions. Cancer immunotherapy is advancing toward a future where engineered T cells may eradicate most metastatic solid tumors. Colon cancer should be far less common because repeated colonoscopy can detect and remove precancerous lesions before malignancy develops. ApoB is the most useful lipid marker for ASCVD risk, and lowering it early and aggressively may nearly eliminate atherosclerotic events. Time-restricted feeding likely helps mainly by reducing calories, not because of a unique metabolic advantage of fasting itself. Many people, especially middle-aged women, underconsume protein and lose lean mass when dieting or fasting too aggressively. Exercise is the most accessible and potent longevity tool, with cardiorespiratory fitness, strength, and grip strength all strongly tied to outcomes. NAD precursors have not yet shown convincing phenotypic benefits in healthy aging despite raising NAD levels. Psychedelics may be useful adjuncts to psychotherapy, but the molecule alone is not the solution. Trazodone appears to be a better sleep-maintenance option than phenibut or Ambien because it preserves sleep architecture better. F1 performance depends on driver skill, tires, engine, chassis, and strategy, making it more complex than many mainstream sports.

Data Points: Podcast milestone: 200th episode / discussion framed around episodes 100-200 - Special anniversary episode revisiting changed views Book manuscript length: ~200,000 words reduced toward ~120,000 words - Atiayah discusses editing his book down substantially Cancer deaths in the U.S.: ~600,000 in 2020 - Used to frame the burden of cancer GI cancer deaths: ~170,000 of 600,000 - Highlights digestive system cancers as a major target for screening Immunotherapy response rate with IL-2 in select cancers: 10-20% - Metastatic melanoma and renal cell cancer responses to high-dose IL-2 ApoB 20th percentile: ~78 mg/dL - Population reference point for ApoB distribution ApoB 10th percentile: ~70 mg/dL - Population reference point for ApoB distribution ApoB 5th percentile: ~62 mg/dL - Used to argue for a practical ApoB ceiling around 60 ApoB 50th percentile: ~97-100 mg/dL - Population reference point for ApoB distribution ApoB 80th percentile: ~118-120 mg/dL - Population reference point for ApoB distribution ApoB 95th percentile: ~140 mg/dL - Population reference point for ApoB distribution Protein RDA: ~0.8 g/kg/day - Atiayah argues this is too low for thriving Suggested protein intake: ~2 g/kg/day or ~1 g/lb body weight - His preferred target for many adults Potential protein toxicity threshold: ~3-4 g/kg/day - Where kidney stress may become more relevant Phenibut availability: Essentially unavailable legally in the U.S. - Cited as the reason trazodone gained favor Trazodone dose range for sleep: 25-100 mg nightly - Typical effective maintenance-sleep dose Dead hang record: 4 minutes 35 seconds - Used as an example of grip strength Shoulder surgery recovery: ~8-9 months - Labrum repair recovery timeline F1 pit stop time loss: ~25-26 seconds - Approximate time lost per pit stop including pit lane transit F1 tire change time: ~3 seconds in 2022; just over 2 seconds in 2021 - Actual tire swap time inside the pit stop F1 qualifying lap vs race lap at Interlagos: ~1:08 qualifying vs ~1:11 race - Illustrates how much faster qualifying setup can be F1 pole position record cited for Senna: 63 poles in 161 races - Used to illustrate Ayrton Senna’s qualifying dominance

Pivotal Quotes: "You have to invest based on strong convictions, but they need to be loosely held." — Peter Atiyah: Explaining the philosophy behind updating beliefs with new evidence "Nobody should ever die from colon cancer." — Peter Atiyah: Arguing for much more aggressive colonoscopy-based screening "I think the answer is probably yes." — Peter Atiyah: Responding to whether lowering ApoB to 20-30 mg/dL in young adults could eliminate ASCVD

Implications: Listeners are encouraged to treat health advice as iterative, prioritize screening, ApoB control, protein, and exercise, and be skeptical of hype around NAD or psychedelics. The episode also signals a more competitive F1 season with strategy and setup mattering more than ever.